VEGFA and osteonecrosis: ESWT effectively treat both early and late-stage osteonecrosis of the femoral head by promoting angiogenesis33,34, which prevents the collapse of the femoral head due to increased VEGF expression and activation of the nitric oxide signaling pathway in the necrotic subchondral bone33.